annual cash & cash equivalents:
$256.17M+$85.86M(+50.41%)Summary
- As of today (September 14, 2025), LGND annual cash & cash equivalents is $256.17 million, with the most recent change of +$85.86 million (+50.41%) on December 31, 2024.
- During the last 3 years, LGND annual cash & cash equivalents has fallen by -$84.94 million (-24.90%).
- LGND annual cash & cash equivalents is now -76.07% below its all-time high of $1.07 billion, reached on December 31, 2019.
Performance
LGND Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$245.02M+$36.12M(+17.29%)Summary
- As of today (September 14, 2025), LGND quarterly cash & cash equivalents is $245.02 million, with the most recent change of +$36.12 million (+17.29%) on June 30, 2025.
- Over the past year, LGND quarterly cash & cash equivalents has increased by +$18.09 million (+7.97%).
- LGND quarterly cash & cash equivalents is now -83.71% below its all-time high of $1.50 billion, reached on March 31, 2019.
Performance
LGND quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LGND Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.4% | +8.0% |
| 3 y3 years | -24.9% | +65.6% |
| 5 y5 years | -76.1% | -69.8% |
LGND Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.9% | +50.4% | -21.1% | +101.8% |
| 5 y | 5-year | -76.1% | +50.4% | -69.8% | +101.8% |
| alltime | all time | -76.1% | +1969.0% | -83.7% | >+9999.0% |
LGND Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $245.02M(+17.3%) |
| Mar 2025 | - | $208.90M(-18.5%) |
| Dec 2024 | $256.17M(+50.4%) | $256.17M(+16.6%) |
| Sep 2024 | - | $219.64M(-3.2%) |
| Jun 2024 | - | $226.93M(-26.9%) |
| Mar 2024 | - | $310.59M(+82.4%) |
| Dec 2023 | $170.31M(-19.6%) | $170.31M(-10.6%) |
| Sep 2023 | - | $190.50M(-13.0%) |
| Jun 2023 | - | $219.04M(-22.5%) |
| Mar 2023 | - | $282.67M(+33.4%) |
| Dec 2022 | $211.87M(-37.9%) | $211.87M(+74.5%) |
| Sep 2022 | - | $121.41M(-17.9%) |
| Jun 2022 | - | $147.94M(-27.5%) |
| Mar 2022 | - | $204.00M(-40.2%) |
| Dec 2021 | $341.11M(-17.1%) | $341.11M(+5.5%) |
| Sep 2021 | - | $323.21M(+7.0%) |
| Jun 2021 | - | $301.98M(-11.1%) |
| Mar 2021 | - | $339.55M(-17.5%) |
| Dec 2020 | $411.53M(-61.6%) | $411.53M(-48.3%) |
| Sep 2020 | - | $795.26M(-1.9%) |
| Jun 2020 | - | $810.61M(+4.9%) |
| Mar 2020 | - | $772.42M(-27.9%) |
| Dec 2019 | $1.07B(+39.5%) | $1.07B(-6.9%) |
| Sep 2019 | - | $1.15B(-17.5%) |
| Jun 2019 | - | $1.39B(-7.3%) |
| Mar 2019 | - | $1.50B(+96.0%) |
| Dec 2018 | $767.19M(+280.4%) | $767.19M(-33.6%) |
| Sep 2018 | - | $1.16B(+13.7%) |
| Jun 2018 | - | $1.02B(+248.3%) |
| Mar 2018 | - | $291.89M(+44.7%) |
| Dec 2017 | $201.66M(+43.0%) | $201.66M(-0.3%) |
| Sep 2017 | - | $202.26M(+17.2%) |
| Jun 2017 | - | $172.63M(+8.3%) |
| Mar 2017 | - | $159.37M(+13.0%) |
| Dec 2016 | $141.05M(-29.6%) | $141.05M(+13.6%) |
| Sep 2016 | - | $124.11M(+16.0%) |
| Jun 2016 | - | $106.95M(-5.5%) |
| Mar 2016 | - | $113.20M(-43.5%) |
| Dec 2015 | $200.22M(+19.7%) | $200.22M(+6.6%) |
| Sep 2015 | - | $187.90M(+3.1%) |
| Jun 2015 | - | $182.21M(+2.8%) |
| Mar 2015 | - | $177.22M(+5.9%) |
| Dec 2014 | $167.34M(+947.2%) | $167.34M(-10.3%) |
| Sep 2014 | - | $186.59M(+747.1%) |
| Jun 2014 | - | $22.03M(-12.8%) |
| Mar 2014 | - | $25.25M(+58.0%) |
| Dec 2013 | $15.98M(+29.1%) | $15.98M(+388.5%) |
| Sep 2013 | - | $3.27M(-44.8%) |
| Jun 2013 | - | $5.92M(+17.6%) |
| Mar 2013 | - | $5.04M(-59.3%) |
| Dec 2012 | $12.38M(-27.3%) | $12.38M(+75.7%) |
| Sep 2012 | - | $7.05M(-32.2%) |
| Jun 2012 | - | $10.38M(-8.0%) |
| Mar 2012 | - | $11.29M(-33.7%) |
| Dec 2011 | $17.04M | $17.04M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $13.44M(-18.6%) |
| Mar 2011 | - | $16.52M(-27.2%) |
| Dec 2010 | $22.70M(-57.4%) | $22.70M(-41.9%) |
| Mar 2010 | - | $39.06M(-26.6%) |
| Dec 2009 | $53.23M(-34.0%) | $53.23M(+20.5%) |
| Sep 2009 | - | $44.19M(-20.4%) |
| Jun 2009 | - | $55.51M(+5.5%) |
| Mar 2009 | - | $52.60M(-34.8%) |
| Dec 2008 | $80.67M(-28.3%) | $80.67M(-18.0%) |
| Sep 2007 | - | $98.39M(-14.7%) |
| Jun 2007 | - | $115.40M(+261.9%) |
| Sep 2006 | - | $31.89M(-47.5%) |
| Jun 2006 | - | $60.78M(-10.2%) |
| Mar 2006 | - | $67.70M(-8.2%) |
| Sep 2005 | - | $73.79M(+8.1%) |
| Jun 2005 | - | $68.27M(-23.6%) |
| Mar 2005 | - | $89.41M(-20.5%) |
| Dec 2004 | $112.49M(+375.4%) | $112.49M(+39.9%) |
| Sep 2004 | - | $80.41M(-6.4%) |
| Jun 2004 | - | $85.88M(-11.6%) |
| Mar 2004 | - | $97.18M(+12.0%) |
| Sep 2003 | - | $86.75M(+107.3%) |
| Jun 2003 | - | $41.84M(+23.1%) |
| Mar 2003 | - | $33.98M(-3.7%) |
| Sep 2002 | - | $35.28M(-17.1%) |
| Jun 2002 | - | $42.56M(+13.1%) |
| Mar 2002 | - | $37.62M(-4.6%) |
| Sep 2001 | - | $39.42M(-13.5%) |
| Jun 2001 | - | $45.56M(+11.4%) |
| Mar 2001 | - | $40.88M(+72.8%) |
| Dec 2000 | $23.66M(-71.6%) | $23.66M(-25.0%) |
| Sep 2000 | - | $31.56M(-32.1%) |
| Jun 2000 | - | $46.49M(+1.3%) |
| Sep 1999 | - | $45.88M(+36.4%) |
| Jun 1999 | - | $33.64M(-28.0%) |
| Mar 1999 | - | $46.70M(+14.5%) |
| Sep 1998 | - | $40.79M(-17.0%) |
| Jun 1998 | - | $49.15M(-20.4%) |
| Mar 1998 | - | $61.78M(-0.8%) |
| Dec 1997 | $83.23M(+3.2%) | $62.30M(+364.9%) |
| Sep 1997 | - | $13.40M(-24.3%) |
| Jun 1997 | - | $17.70M(-22.4%) |
| Mar 1997 | - | $22.80M(-34.5%) |
| Dec 1996 | $80.65M(+15.0%) | $34.80M(+397.1%) |
| Sep 1996 | - | $7.00M(-37.5%) |
| Jun 1996 | - | $11.20M(-32.1%) |
| Mar 1996 | - | $16.50M(+3.1%) |
| Dec 1995 | $70.14M(+82.7%) | $16.00M(+31.1%) |
| Sep 1995 | - | $12.20M(-8.3%) |
| Mar 1995 | - | $13.30M(+75.0%) |
| Dec 1994 | $38.40M(-9.3%) | $7.60M(-37.2%) |
| Sep 1994 | - | $12.10M(+1628.6%) |
| Jun 1994 | - | $700.00K(-66.7%) |
| Mar 1994 | - | $2.10M |
| Dec 1993 | $42.35M(-23.8%) | - |
| Dec 1992 | $55.60M | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual cash & cash equivalents year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly cash & cash equivalents year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of LGND is $256.17M
What is the all time high annual cash & cash equivalents for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual cash & cash equivalents is $1.07B
What is Ligand Pharmaceuticals Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, LGND annual cash & cash equivalents has changed by +$85.86M (+50.41%)
What is Ligand Pharmaceuticals Incorporated quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of LGND is $245.02M
What is the all time high quarterly cash & cash equivalents for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly cash & cash equivalents is $1.50B
What is Ligand Pharmaceuticals Incorporated quarterly cash & cash equivalents year-on-year change?
Over the past year, LGND quarterly cash & cash equivalents has changed by +$18.09M (+7.97%)